Stay updated on Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the study record for pembrolizumab with chemotherapy for thyroid and salivary gland tumors, including study details, participant criteria, outcomes, and record dates, instead of an access-denied error.
    Difference
    50%
    Check dated 2026-11-09T13:18:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:17:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs about the change.
    Difference
    1%
    Check dated 2026-10-26T15:44:40.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.1 to v3.7.2 while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T21:47:58.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T04:18:53.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating the page is inaccessible. The added content includes the 403 HTML shell and the Forbidden message.
    Difference
    19%
    Check dated 2026-09-21T22:17:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.